But for the average breast cancer patient who has neither the BRCA1 or BRCA2 gene mutation nor a close relative with breast cancer (Jolie's mother, for example, died from ovarian cancer), the risk of a new breast cancer in the nonaffected breast is less than 1%.

CNN: When removing breast is not the answer

In New York, for one, before a surgeon can perform a mastectomy or lumpectomy on a breast cancer patient, that patient must meet with a plastic surgeon to learn her options.

FORBES: Breast Cancer Survivors Feel "Selfish" About Reconstructive Surgery

Patient demand was instrumental in improving outcomes for adults with HIV and breast cancer.

BBC: Children 'missing out on research benefits'

Results from a 9, 366-patient trial showed that those on Arimidex had a 17% reduction in the risk of breast cancer recurrence compared with patients on Nolvadex.

FORBES: The World's Billionaires